Di MarzoV, MelckD, BisognoT, et al.Endocannabinoids: Endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci, 1998; 21:521–528.
2.
WhitingPF, WolffRF, DeshpandeS, et al.Cannabinoids for medical use: A systematic review and meta-analysis. JAMA, 2015; 313:2456–2473.
3.
U.S. Food and Drug Administration. (2017). Warning letters and test results for cannabidiol-related products. Online document at: https://www.fda.gov/news-events/public-health-focus/warning-letters-and-test-results-cannabidiol-related-products, accessed July30, 2019.
4.
National Cancer Institute PDQ Cancer Information Summaries forIntegrative, Alternative and ComplementaryTherapies website. Online document at: https://www.cancer.gov/publications/pdq/information-summaries/cam, accessed July16, 2019.
5.
LeasEC, NoblesAL, CaputiTL, et al.Trends in internet searches for cannabidiol (CBD) in the United States. JAMA Netw Open, 2019; 2:e1913853.
6.
BergamaschiMM, QueirozRHC, ZuardiAW, et al.Safety and side effects of cannabidiol, a cannabis sativa constituent. Curr Drug Saf, 2011; 6:237–249.
7.
OpitzBJ, OstroffML, WhitmanAC. The potential clinical implications and importance of drug interactions between anticancer agents and cannabidiol in patients with cancer. J Pharm Pract, 2019. DOI: 10.1177/0897190019828920
